Ozempic-like fat jabs ‘boost men's sex lives – reversing testosterone drops'
Click to share on Facebook (Opens in new window)
WEIGHT loss jabs could boost men's sex lives, a study suggests.
Research found injections like Wegovy and Mounjaro can raise blokes' low testosterone levels.
Sign up for Scottish Sun
newsletter
Sign up
1
More than a million people in the UK use weight loss injections (stock image)
Credit: Getty
The hormone is a big factor in the male sex drive, known as libido, as well as a driver of strength, muscle gain and fat loss.
Testosterone levels commonly decline with age or when someone is obese or has type 2 diabetes – amounting to millions of men in the UK.
A study by the St Louis University Hospital in Missouri, USA, tracked 110 men in their 40s, 50s and 60s who were being treated with semaglutide – aka Ozempic or Wegovy – or tirzepatide, known as Mounjaro.
At the start of their treatment just 53 per cent of the men had normal testosterone levels.
Symptoms of low testosterone can include tiredness, weakness and fat gain, feeling depressed, brain fog, and a lack of desire or inability to perform in the bedroom.
Treatment increased rate of healthy testosterone
After 18 months of treatment with the fat jabs, the proportion of men with healthy hormone levels increased to 77 per cent.
Study author Dr Shellsea Portillo Canales said: 'Our study is among the first to provide compelling evidence that low testosterone can be reversed with the use of commonly prescribed anti-obesity medications.
'Doctors and their patients can now consider this class of medications not only for the treatment of obesity and to control blood sugar, but also to benefit men's reproductive health.'
More than 1.5million Brits are thought to be taking weight loss injections, known as GLP-1 receptor agonists.
NHS prescriptions have rocketed from 1.4million in 2023 to 2.7million in 2024, and more than a million people are paying for them privately.
I went from 27 lbs in six weeks with Mounjaro after 15 years of trying to lose weight it has completely changed my life
As well as rapid weight loss and treatment for type 2 diabetes, research suggests the jabs may also reduce the risk of some cancers, heart diseases and dementia.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
2 hours ago
- Scottish Sun
The £1.80 juice that ‘lowers your blood pressure – slashing risk of killer heart attack and stroke'
Scroll down to find out other foods that can help BEET IT The £1.80 juice that 'lowers your blood pressure – slashing risk of killer heart attack and stroke' Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A VEGETABLE juice available in supermarkets can lower your blood pressure by killing bad mouth bacteria, a study found. About one in three Brits have high blood pressure, raising their risk of heart disease, strokes and dementia. Sign up for Scottish Sun newsletter Sign up 1 Millions of people in the UK have high blood pressure (stock image) Credit: Alamy Millions take medication to reduce the danger but your diet can also help. Researchers at Exeter University found that nitrates in beetroot juice can maintain a healthy balance of bacteria in the mouth and gut in older patients. People in their 60s and 70s saw a decrease in blood pressure after two weeks of drinking two shots of juice per day. They used juice concentrate shots that cost about £1.80 each and are equal to a pint of pressed juice, costing about £1.65. Nitrate from the juice increases the body's production of nitric oxide, which helps blood vessels to relax and regulates blood pressure. Veg alternatives if you don't like beetroot Study author Professor Anni Vanhatalo said: 'We know that a nitrate-rich diet has health benefits and older people produce less of their own nitric oxide as they age. 'Encouraging older adults to consume more nitrate-rich vegetables could have significant long term health benefits. 'The good news is that if you don't like beetroot, there are many nitrate-rich alternatives like spinach, rocket, fennel, celery and kale.' The study, published in the journal Free Radical Biology and Medicine, compared the effects in 39 under-30s and 36 pensioners in their 60s and 70s. Both age groups had a 'significant' change in the balance of bacteria in their mouths. What is high blood pressure and what is a normal reading? Experts increasingly believe the balance of bugs in our mouth and gut has a huge influence on overall health. Beetroot juice did not have the same blood pressure lowering effect on younger participants. Older people saw an increase in health-boosting bacteria Neisseria, and a decrease in a bug called Prevotella. This in turn led to a decrease in blood pressure readings. Dr Lee Beniston, of the Biotechnology and Biological Sciences Research Council, said: 'This research is a great example of how bioscience can help us better understand the complex links between diet, the microbiome and healthy ageing. 'It opens up new opportunities for improving vascular health through nutrition.'
The Independent
3 hours ago
- The Independent
NHS launches major search for donors with rare blood types
The NHS has launched a pioneering initiative to identify and secure blood donations from individuals with rare blood types, ensuring patients receive "precision-matched" transfusions. This UK-first drive aims to mitigate the risk of adverse reactions for those requiring blood. Scientists have embarked on a large-scale research project, DNA -testing the blood of 77,000 donors to date. Blood collected from these rare donors will be frozen, creating a vital reserve for others with the same specific blood type. Crucially, this stored blood will also be available to the donor themselves, should they ever require a transfusion. NHS Blood and Transplant (NHSBT) underscores the critical importance of precise blood matching, citing the intricate nature of blood groups, with 362 known types. The organisation stated that blood matching is "vital" given this complexity, highlighting the necessity of this new approach to enhance patient safety. This is the first time that blood types have been DNA tested in the UK at-scale, NHSBT said. Dozens of rare blood donors have been identified during the process and it is hoped the number will rise to hundreds. This means that blood from these donors can be used as 'personalised, precision-matched transfusion' for those in need. This can help avoid severe transfusion reactions – where the body sees the transfused blood as 'foreign' and rejects it. People who are particularly at risk of these reactions are those who regularly receive blood donations including those with sickle cell disorder and thalassaemia. Experts hailed the project as the 'first major step' towards rolling out precision-matched blood more widely. Dr Gail Miflin, chief medical officer at NHSBT, said: 'Taking these 77,000 donors and testing their blood to such a precise level has been an incredible undertaking and will work to significantly change the way we issue blood – especially to those patients at higher risk of transfusion-related reactions. 'We will be able to match to an increasing number of blood groups, ensuring that patients have blood that is most similar to their own and reducing the risk of any reactions. 'It is an example of just how we are driving innovation which can radically improve patient outcomes.' NHSBT's genomics programme director, Kate Downes, added: 'This inventory of blood will enhance our capacity to find units with rare blood groups for difficult to match patients as well as provide better matched units for patients who have an increased risk of transfusion reactions, aiding us in our mission to save and improve even more lives. 'This genotyping is a first major step towards rolling out precision-matched blood more widely, which would be a landmark change in how blood is matched.'
Scottish Sun
4 hours ago
- Scottish Sun
Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds
Plus, all the ways you can lower your dementia risk if you have type 2 diabetes WIN WIN Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, say scientists. While both medications demonstrate neuroprotective properties, no comparison has been made up until now. Sign up for Scottish Sun newsletter Sign up 1 GLP-1 receptor agonists have recently gained popularity as a weight loss medication Credit: Getty Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated. In recent times, GLP-1 receptor agonists have gained popularity as a weight loss medication due to their ability to suppress appetite and promote feelings of fullness. Previously published research indicated people with type 2 diabetes have a significantly increased risk of developing dementia, with some studies reporting a 70 per cent higher risk compared to those without diabetes. And both GLP-1 receptor agonists and metformin have been shown to protect the brains of people with type 2 diabetes. But in the largest study of its kind, published in BMJ Open Diabetes Research & Care, GLP-1 receptor agonists were found to trump metformin when it comes to dementia risk. Researchers analysed health records from the period 2004 to 2024 to track the development of dementia in patients with type 2 diabetes who were treated with either GLP-1 receptor agonists or metformin for at least six consecutive months. While there was no significant difference in vascular dementia risk between the two types of drug, GLP-1 receptor agonist use was associated with a significantly lower risk of developing dementia, overall. Specifically, taking GLP-1 receptor agonists was linked to a lower risk of developing Alzheimer's disease, and a 25 per cent lower risk of developing non-vascular dementias than metformin use. These positive effects were evident across all age groups, but with the strongest effect among the over 60s, women, and those of white ethnicity. Risk of death from any cause was also found to be lower - nearly 5 per cent of those treated with GLP-1 receptor agonists died compared with nearly 9 per cent of those treated with metformin. The 14 science-backed ways to prevent dementia 'Both medications demonstrate neuroprotective properties, such as reducing neuroinflammation and oxidative stress, improving insulin sensitivity, and enhancing cerebrovascular health, which likely contribute to their benefits in overall dementia,' explain the researchers. But unlike metformin, GLP-1 receptor agonists exert direct central nervous system effects by crossing the blood-brain barrier, they add. The researchers point out their tracking period, while sufficient for observing dementia outcomes, may not fully capture long-term cognitive effects, especially given the progressive nature of Alzheimer's disease. But they conclude: "Given the severe societal, familial , and economic burden of diabetes-related dementia, these findings raise important considerations about the tole of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management. "While further long-term studies are warranted to validate these results, integrating GLP-1 [receptor agonists] as primary therapeutic agents may represent a paradigm shift in preventing the cognitive complications of diabetes.' All GLP-1 medicines are prescription only medicines, which means they can only be prescribed by a healthcare professional. GLP-1 medicines can also be purchased privately. If you want to get a GLP-1 medicine privately, a consultation with a healthcare professional must happen before the prescription can be issued, so the prescriber can carry out proper checks and make sure you are aware of the benefits and risks of taking the medicine. GLP-1 medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional. The Medicines & Healthcare products Regulatory Agency (MHRA) has had reports of people experiencing severe side effects from fake GLP-1 medicines.
